FDA issues new heart risk warnings for Pfizer, Moderna COVID vaccines - should you be worried?
What's Behind the FDA's New Warning?
Who Faces the Highest Risk?
Live Events
What's Changing in the Vaccine Labels?
What's the FDA Doing Next?
FAQs
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
The US Food and Drug Administration (FDA) has warned that COVID-19 vaccines, which are manufactured by Pfizer and Moderna, have the potential for cardiac risks, as per a report.These warnings were first proposed in letters, which were sent to both companies in April, providing additional information about the potential risks of myocarditis and/or pericarditis associated with the two vaccines, as reported by the Cardiovascular Business report. Myocarditis and pericarditis have the possibility of leading to long-term heart damage, according to the report.ALSO READ: Meet Trapit Bansal, Meta's new AI superintelligence team hire - Is Meta poaching top talent from OpenAI? FDA's latest update covers Pfizer's Comirnaty vaccine and Moderna's Spikevax vaccine, while both companies had mentioned text about myocarditis and pericarditis in the labelling for these vaccines since 2021, but the FDA wanted more information added to these warnings that specifically mentions the increased risks for young men, as per the Cardiovascular Business report.ALSO READ: After Canada, now US: College graduates face the toughest job market in decades – what's gone wrong? According to the Cardiovascular Business report, the new labeling for both the vaccines is now required to include the following text, as per FDA's latest update:"Based on analyses of commercial health insurance claims data from inpatient and outpatient settings, the estimated unadjusted incidence of myocarditis and/or pericarditis during the period 1 through 7 days following administration of the 2023-2024 Formula of mRNA COVID-19 vaccines was approximately 8 cases per million doses in individuals 6 months through 64 years of age and approximately 27 cases per million doses in males 12 through 24 years of age," as quoted in the report.The label should also include, "Follow-up information on cardiovascular outcomes in hospitalized patients who had been diagnosed with COVID-19 vaccine-associated myocarditis is available from a longitudinal retrospective observational study. Most of these patients had received a two-dose primary series of an mRNA COVID-19 vaccine prior to their diagnosis. In this study, at a median follow-up of approximately 5 months post-vaccination, persistence of abnormal cardiac magnetic resonance imaging (CMR) findings that are a marker for myocardial injury was common. The clinical and prognostic significance of these CMR findings is not known," as quoted by the Cardiovascular Business report.ALSO READ: Top economist warns: US faces a crisis worse than recession — here's what could be coming While, FDA has also emphasised that it plans to keep tracking the safety of COVID-19 vaccines from now on, as per the report.The agency said, 'Continuous monitoring and assessment of the safety of all vaccines, including the mRNA COVID-19 vaccines, is an FDA priority and we remain committed to informing the public when we learn new information about these vaccines,' adding, 'In addition, as part of the approvals of Comirnaty and Spikevax, each manufacturer is required by FDA to conduct a study to assess if there are long-term heart effects in people who have had myocarditis after receiving an mRNA COVID-19 vaccine. These studies are underway,' quoted by the Cardiovascular Business report.The FDA wants the public to have clearer information about rare heart-related risks linked to COVID-19 mRNA vaccines, especially for young men, as per the Cardiovascular Business report.Yes, the FDA continues to support their use, but these warnings are about rare side effects, as per the Cardiovascular Business report.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
32 minutes ago
- NDTV
Seasons And Geographic Locations Strongly Influence Sleep Patterns: Study
New Delhi: Sleep patterns are significantly influenced by the day of the week, the season, and geographic locations, according to a study. The study, led by researchers from Flinders University in South Australia, is based on data from more than 116,000 adults and over 73 million nights of sleep. The team used an under-mattress device to objectively track sleep duration and timing across 3.5 years, Xinhua news agency reported. The study finds that sleep is shaped not just by personal habits, but by environmental factors like daylight, temperature, and weekly routines. "Our findings underscore the seasonal nature of human sleep, and that it is influenced by demographics and geography," said Hannah Scott, a sleep health expert at Flinders University. People in the Northern Hemisphere sleep 15 to 20 minutes longer in winter, while those in the Southern Hemisphere sleep less in summer. "Interestingly we found that the farther you live from the equator, the greater the seasonal variation in sleep," Ms. Scott said. People go to bed later and sleep in longer on weekends, recovering some lost sleep, especially middle-aged adults balancing work and family. These irregular patterns are increasingly linked to negative health effects, according to the study published in Sleep. The study found a gradual decline in sleep, with people sleeping about 2.5 minutes less per night from 2020 to 2023, possibly due to the ongoing effects of the Covid-19 pandemic. "Irregular sleep is more than just feeling tired -- it can be a health risk and understanding how our routines and environments affect sleep is a helpful step towards improving it," said Danny Eckert from Flinders University. Although the study focused on tech-savvy users and didn't account for factors like pets or partners, it underscores how the environment shapes sleep, reminding people to consider time and season for better rest, said the researchers.
Time of India
an hour ago
- Time of India
'Razor Blade throat' emerges as new symptom of Covid 19: Why does it hurt so much
After lying low for a couple of years, COVID-19 has made a comeback, with fresh cases emerging all across the world. The new variant, nicknamed Nimbus remains under observation, and doctors say that it does not cause severe illness, and most people are recovering at home by resting it out, and keeping themselves hydrated. However, one symptom that is increasingly being seen with this new variant is a severe throat pain, also known as "Razor Blade throat". It is said that this pain is so sharp that it feels like swallowing razor blades (hence the name). But, what is this new symptom, and why does it hurt so much? We take a look... What Is the 'Razor Blade' Sore Throat The 'razor blade' sore throat is a term used to describe the excruciating throat pain caused by the Nimbus variant of COVID-19. Unlike the milder sore throats people experienced with earlier COVID strains, this one feels extremely sharp and painful. Many patients say swallowing food or even water seems like a Herculean task. This symptom was first reported in China when the variant emerged in May 2025 and has since spread to the U.S. and other countries. Now, Nimbus accounts for about a third of COVID cases in the U.S. Why does it cause so much pain COVID-19 is essentially a respiratory infection that infects the body through the nose, mouth, and throat, which are part of the upper respiratory tract. In the early days of infection, the virus multiplies in the lining of the throat. This triggers the body's immune system to react, causing inflammation and swelling in the throat tissues. With the Nimbus variant, this immune response seems especially strong or focused in the throat area. Doctors say these could be some of the reasons... New variant: Nimbus may have the capacity for infecting throat cells more aggressively than earlier variants, causing more damage and irritation. Immune system reaction: Because many people are vaccinated or have had COVID before, their immune systems may respond more strongly to Nimbus. The throat has many lymph nodes and immune cells, which can cause intense inflammation when activated, as a means to protect the body. Change in virus pattern: As the virus changes, its patterns also shift. Earlier variants caused more loss of taste and smell, but newer ones like Nimbus cause more throat pain. How is it different from regular sore throats Sore throats can be caused by many things like the common cold, flu, allergies, acid reflux, or bacterial infections such as strep throat. What makes the COVID 'razor blade' sore throat stand out is the extreme sharpness and severity of the pain. (though extreme throat pain is not exclusive to Covid 19) Doctors warn that because this symptom overlaps with other illnesses, it can be hard to tell if a sore throat is from COVID or something else. If the pain is severe, or lasts longer than a few days, it's important to get tested for COVID-19. Even if you don't have Covid, the doctor will suggest if you need antibiotics to calm the infection or not. Other symptoms Besides the severe sore throat, Nimbus causes symptoms similar to other COVID variants, including: Fever (can be high or low grade) Whooping Cough Fatigue Muscle aches Headaches Loss of taste or smell (less common now) Some people may also experience swollen lymph nodes or difficulty swallowing because of throat inflammation. How can you get relief While the pain can be intense, there are ways to ease the discomfort at home: Stay hydrated: Drink plenty of fluids like water, warm tea, or broth to soothe the throat and prevent dryness. However, stay away from extreme hot beverages as well, as they can further irritate your throat. Lukewarm is the best temperature. Use throat lozenges: These can numb the throat and reduce pain temporarily. Gargle with warm (not hot) salt water: This helps reduce inflammation and kills some bacteria in the throat. Rest your voice: Avoid talking too much to prevent further irritation. Over-the-counter pain relievers: Medicines like acetaminophen or ibuprofen can help reduce pain and inflammation. (check with a doctor first) If your sore throat worsens, lasts more than a week, or is accompanied by difficulty breathing or swallowing, seek medical attention immediately. Sources: WebMD, 'Why COVID 'Razor Blade' Sore Throat Hurts So Bad,' June 26, 2025 Everyday Health, 'How to Cope With a COVID-19 Sore Throat,' June 23, 2025 Healthline, 'New COVID Variant Nimbus May Cause Painful 'Razor Blade Throat' Symptom,' June 19, 2025
Economic Times
11 hours ago
- Economic Times
FDA issues new heart risk warnings for Pfizer, Moderna COVID vaccines - should you be worried?
What's Behind the FDA's New Warning? Who Faces the Highest Risk? Live Events What's Changing in the Vaccine Labels? What's the FDA Doing Next? FAQs (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel The US Food and Drug Administration (FDA) has warned that COVID-19 vaccines, which are manufactured by Pfizer and Moderna, have the potential for cardiac risks, as per a warnings were first proposed in letters, which were sent to both companies in April, providing additional information about the potential risks of myocarditis and/or pericarditis associated with the two vaccines, as reported by the Cardiovascular Business report. Myocarditis and pericarditis have the possibility of leading to long-term heart damage, according to the READ: Meet Trapit Bansal, Meta's new AI superintelligence team hire - Is Meta poaching top talent from OpenAI? FDA's latest update covers Pfizer's Comirnaty vaccine and Moderna's Spikevax vaccine, while both companies had mentioned text about myocarditis and pericarditis in the labelling for these vaccines since 2021, but the FDA wanted more information added to these warnings that specifically mentions the increased risks for young men, as per the Cardiovascular Business READ: After Canada, now US: College graduates face the toughest job market in decades – what's gone wrong? According to the Cardiovascular Business report, the new labeling for both the vaccines is now required to include the following text, as per FDA's latest update:"Based on analyses of commercial health insurance claims data from inpatient and outpatient settings, the estimated unadjusted incidence of myocarditis and/or pericarditis during the period 1 through 7 days following administration of the 2023-2024 Formula of mRNA COVID-19 vaccines was approximately 8 cases per million doses in individuals 6 months through 64 years of age and approximately 27 cases per million doses in males 12 through 24 years of age," as quoted in the label should also include, "Follow-up information on cardiovascular outcomes in hospitalized patients who had been diagnosed with COVID-19 vaccine-associated myocarditis is available from a longitudinal retrospective observational study. Most of these patients had received a two-dose primary series of an mRNA COVID-19 vaccine prior to their diagnosis. In this study, at a median follow-up of approximately 5 months post-vaccination, persistence of abnormal cardiac magnetic resonance imaging (CMR) findings that are a marker for myocardial injury was common. The clinical and prognostic significance of these CMR findings is not known," as quoted by the Cardiovascular Business READ: Top economist warns: US faces a crisis worse than recession — here's what could be coming While, FDA has also emphasised that it plans to keep tracking the safety of COVID-19 vaccines from now on, as per the agency said, 'Continuous monitoring and assessment of the safety of all vaccines, including the mRNA COVID-19 vaccines, is an FDA priority and we remain committed to informing the public when we learn new information about these vaccines,' adding, 'In addition, as part of the approvals of Comirnaty and Spikevax, each manufacturer is required by FDA to conduct a study to assess if there are long-term heart effects in people who have had myocarditis after receiving an mRNA COVID-19 vaccine. These studies are underway,' quoted by the Cardiovascular Business FDA wants the public to have clearer information about rare heart-related risks linked to COVID-19 mRNA vaccines, especially for young men, as per the Cardiovascular Business the FDA continues to support their use, but these warnings are about rare side effects, as per the Cardiovascular Business report.
